Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder

Brain Research

Volumn 1459, Issue , 2012, Pages 91-99

  Bielau, Hendrik ^a   Brisch, Ralf ^a   Bernard Mittelstaedt, Jenny ^a   Dobrowolny, Henrik ^a   Gos, Tomasz ^a,b   Baumann, Bruno ^c   Mawrin, Christian ^a   Bernstein, Hans Gert ^a   Bogerts, Bernhard ^a   Steiner, Johann ^a,d  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d PEMBROKE COLLEGE   (United Kingdom)

Author keywords

Bipolar disorder; Major depressive disorder; Mood disorder; Nitric oxide; nNOS; Postmortem

Indexed keywords

AMITRIPTYLINE; DIAZEPAM; GLUTAMIC ACID; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM CARBONATE; NEURONAL NITRIC OXIDE SYNTHASE; NITRAZEPAM; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN SIZE; CAUSE OF DEATH; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEFT HEMISPHERE; LOCUS CERULEUS; MAJOR DEPRESSION; MALE; NERVE CELL; NEUROTRANSMISSION; PRIORITY JOURNAL; RIGHT HEMISPHERE; SIGNAL TRANSDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LOCUS COERULEUS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE I; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 84861231165     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.04.022     Document Type: Article

References (88)

1. O. Akyol, S.S. Zoroglu, F. Armutcu, S. Sahin, and A. Gurel Nitric oxide as a physiopathological factor in neuropsychiatric disorders In Vivo 18 2004 377 390 (Pubitemid 39069754)
2. A. Anand, and D.S. Charney Norepinephrine dysfunction in depression J. Clin. Psychiatry 61 Suppl. 10 2000 16 24 (Pubitemid 30485421)
3. M.L. Arbonés, J. Ribera, L. Agulló, M.A. Baltrons, A. Casanovas, V. Riveros-Moreno, and A. García Characteristics of nitric oxide synthase type I of rat cerebellar astrocytes Glia 18 1996 224 232 (Pubitemid 27040273)
4. B. Baumann, P. Danos, S. Diekmann, D. Krell, H. Bielau, C. Geretsegger, C. Wurthmann, H.G. Bernstein, and B. Bogerts Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 212 219 (Pubitemid 29408319)
5. B. Baumann, H. Bielau, D. Krell, M.W. Agelink, S. Diekmann, C. Wurthmann, K. Trübner, H.G. Bernstein, P. Danos, and B. Bogerts Circumscribed numerical deficit of dorsal raphe neurons in mood disorders Psychol. Med. 32 2002 93 103 (Pubitemid 33150506)
6. B. Baumann, D. Krell, H. Dobrowolny, and H. Bielau Mechanisms of action in the prevention of recurrent mood disorders Pharmacopsychiatry 37 Suppl. 2 2004 157 164
7. R. Benavides-Piccione, and J. DeFelipe Different populations of tyrosinehydroxylase- immunoreactive neurons defined by differential expression of nitric oxide synthase in the human temporal cortex Cereb. Cortex 13 2003 297 307 (Pubitemid 36236676)
8. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biol. Psychiatry 47 2000 351 354 (Pubitemid 30109248)
9. H.G. Bernstein, A. Stanarius, B. Baumann, H. Henning, D. Krell, P. Danos, P. Falkai, and B. Bogerts Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics Neuroscience 83 1998 867 875 (Pubitemid 28068907)
10. H.G. Bernstein, G.F. Jirikowski, A. Heinemann, B. Baumann, C. Hornstein, P. Danos, S. Diekmann, H. Sauer, G. Keilhoff, and B. Bogerts Low and infrequent expression of nitric oxide synthase/NADPH-diaphorase in neurons of the human supraoptic nucleus: a histochemical study J. Chem. Neuroanat. 20 2000 177 183
11. H.G. Bernstein, D. Krell, K.H. Braunewell, B. Baumann, E.D. Gundelfinger, S. Diekmann, P. Danos, and B. Bogerts Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia J. Neurocytol. 30 2001 661 670
12. H.G. Bernstein, A. Heinemann, D. Krell, C. Mawrin, H. Bielau, P. Danos, S. Diekmann, G. Keilhoff, B. Bogerts, and B. Baumann Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients Ann. N. Y. Acad. Sci. 973 2002 91 93 (Pubitemid 36124984)
13. H.G. Bernstein, A. Heinemann, D. Krell, H. Dobrowolny, H. Bielau, G. Keilhoff, and B. Bogerts Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus Cell. Mol. Biol. 51 2005 279 284 (Pubitemid 43093379)
14. H.G. Bernstein, G. Keilhoff, J. Steiner, H. Dobrowolny, and B. Bogerts Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy CNS Neurol. Disord. Drug Targets 10 2011 792 807
15. C.W. Berridge, and B.D. Waterhouse The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes Brain Res. Rev. 42 2003 33 84 (Pubitemid 36369264)
16. H. Bielau, C. Mawrin, D. Krell, M.W. Agelink, K. Trübner, R. Davis, T. Gos, B. Bogerts, H.G. Bernstein, and B. Baumann Differences in activation of the dorsal raphe nucleus depending on performance of suicide Brain Res. 1039 2005 43 52 (Pubitemid 40386826)
17. H. Bielau, K. Trübner, D. Krell, M.W. Agelink, H.G. Bernstein, R. Stauch, C. Mawrin, P. Danos, L. Gerhard, B. Bogerts, and B. Baumann Volume deficits of subcortical nuclei in mood disorders. A postmortem study Eur. Arch. Psychiatry Clin. Neurosci. 255 2005 401 412 (Pubitemid 43029829)
18. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 6407 1993 31 39 (Pubitemid 23020772)
19. G.A. Böhme, C. Bon, M. Lemaire, M. Reibaud, O. Piot, J.M. Stutzmann, A. Doble, and J.C. Blanchard Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats Proc. Natl. Acad. Sci. U. S. A. 90 1993 9191 9194 (Pubitemid 23306478)
20. M.P. Bowley, W.C. Drevets, D. Ongür, and J.L. Price Low glial numbers in the amygdala in major depressive disorder Biol. Psychiatry 52 2002 404 412 (Pubitemid 35266731)
21. J.E. Brenman, and D.S. Bredt Synaptic signaling by nitric oxide Curr. Opin. Neurobiol. 7 1997 374 378 (Pubitemid 27321029)
22. W.E. Chrapko, P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder Biol. Psychiatry 56 2004 129 134 (Pubitemid 38844788)
23. W. Chrapko, P. Jurasz, M.W. Radomski, S.L. Archer, S.C. Newman, G. Baker, N. Lara, and J.M. Le Mellédo Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients Neuropsychopharmacology 31 2006 1286 1293 (Pubitemid 43971844)
24. B. Cobb, K.L. Ryan, M.R. Frei, V. Guel-Gomez, and G.A. Mickley Chronic administration of L-NAME in drinking water alters working memory in rats Brain Res. Bull. 38 1995 203 207
25. R.E. Coggeshall, and H.A. Lekan Methods for determining numbers of cells and synapses: a case for more uniform standards of review J. Comp. Neurol. 364 1996 6 15 (Pubitemid 26026631)
26. D. Cotter, D. Mackay, S. Landau, R. Kerwin, and I. Everall Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder Arch. Gen. Psychiatry 58 2001 545 553 (Pubitemid 32523734)
27. L.M. Cruz-Orive Particle shape-size distributions, the general spheroid problem, II: stochastic model and practical guide J. Microsc. 112 1978 153 167
28. A. Dahlstrom, and K. Fuxe Localization of monoamines in the lower brain stem Experientia 20 1964 398 399
29. A. Dhir, and S.K. Kulkarni Nitric oxide and major depression Nitric Oxide 24 2011 125 131
30. K.Q. Do, G. Grima, B. Benz, and T.E. Salt Glial-neuronal transfer of arginine and S-nitrosothiols in nitric oxide transmission Ann. N. Y. Acad. Sci. 962 2002 81 92 (Pubitemid 34592302)
31. P. Fossier, B. Blanchard, C. Ducrocq, C. Leprince, L. Tauc, and G. Baux Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation Neuroscience 93 1999 597 603 (Pubitemid 29329464)
32. J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system Trends Neurosci. 14 1991 60 67
33. J. Garthwaite Concepts of neural nitric oxide-mediated transmission Eur. J. Neurosci. 27 2008 2783 2802 (Pubitemid 351832227)
34. J. Garthwaite, and C.L. Boulton Nitric oxide signaling in the central nervous system Annu. Rev. Physiol. 57 1995 683 706
35. D.C. German, B.S. Walker, K. Manaye, W.K. Smith, D.J. Woodward, and A.J. North The human locus coeruleus: computer reconstruction of cellular distribution J. Neurosci. 8 1988 1776 1788
36. T. Gos, D. Krell, H. Bielau, R. Brisch, K. Trübner, J. Steiner, H.G. Bernstein, Z. Jankowski, and B. Bogerts Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients Eur. Arch. Psychiatry Clin. Neurosci. 258 2008 513 520
37. G. Grima, B. Benz, and K.Q. Do Glutamate-induced release of the nitric oxide precursor, arginine, from glial cells Eur. J. Neurosci. 9 1997 2248 2258 (Pubitemid 28005978)
38. H. Hara, C. Waeber, P.L. Huang, M. Fujii, M.C. Fishman, and M.A. Moskowitz Brain distribution of nitric oxide synthase in neuronal or endothelial nitric oxide synthase mutant mice using [3H]L-NG-nitro-arginine autoradiography Neuroscience 75 1996 881 890 (Pubitemid 26377057)
39. A. Harkin, K.H. Bruce, B. Craft, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test Eur. J. Pharmacol. 372 1999 207 213 (Pubitemid 29255959)
40. R. Hoekstra, D. Fekkes, L. Pepplinkhuizen, A.J. Loonen, S. Tuinier, and W.M. Verhoeven Nitric oxide and neopterin in bipolar affective disorder Neuropsychobiology 54 2006 75 81 (Pubitemid 44699465)
41. B.E. Jones Noradrenergic locus coeruleus neurons: their distant connections and their relationship to neighboring (including cholinergic and GABAergic) neurons of the central gray and reticular formation Prog. Brain Res. 88 1991 15 30
42. B. Karolewicz, I.A. Paul, and L. Antkiewicz-Michaluk Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain Pol. J. Pharmacol. 53 2001 587 596
43. B. Karolewicz, K. Szebeni, C.A. Stockmeier, L. Konick, J.C. Overholser, G. Jurjus, B.L. Roth, and G.A. Ordway Low nNOS protein in the locus coeruleus in major depression J. Neurochem. 91 2004 1057 1066 (Pubitemid 39587444)
44. B. Karolewicz, C.A. Stockmeier, and G.A. Ordway Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression Neuropsychopharmacology 30 2005 1557 1567 (Pubitemid 41153128)
45. B. Karolewicz, K. Szebeni, T. Gilmore, D. Maciag, C.A. Stockmeier, and G.A. Ordway Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression Int. J. Neuropsychopharmacol. 12 2009 143 153
46. J.P. Kiss Role of nitric oxide in the regulation of monoaminergic neurotransmission Brain Res. Bull. 52 2000 459 466
47. V. Klimek, C. Stockmeier, J. Overholser, H.Y. Meltzer, S. Kalka, G. Dilley, and G.A. Ordway Reduced levels of norepinephrine transporters in the locus coeruleus in major depression J. Neurosci. 17 1997 8451 8458 (Pubitemid 27461066)
48. P. Kugler, and D. Drenckhahn Astrocytes and Bergmann glia as an important site of nitric oxide synthase I Glia 16 1996 165 173 (Pubitemid 26309478)
49. D.M. Kuhn, and R. Arthur Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center J. Neurosci. 17 1997 7245 7251 (Pubitemid 27413256)
50. J. Levine, K. Panchalingam, A. Rapoport, S. Gershon, R.J. McClure, and J.W. Pettegrew Increased cerebrospinal fluid glutamine levels in depressed patients Biol. Psychiatry 47 2000 586 593 (Pubitemid 30169251)
51. R. Machado-Vieira, G. Salvadore, L.A. Ibrahim, N. Diaz-Granados, and C.A. Zarate Jr. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders Curr. Pharm. Des. 15 2009 1595 1611
52. D.V. Madison, R.C. Malenka, and R.A. Nicoll Mechanisms underlying long-term potentiation of synaptic transmission Annu. Rev. Neurosci. 14 1991 379 397
53. R.C. Malenka Synaptic plasticity in the hippocampus: LTP and LTD Cell 78 1994 535 538 (Pubitemid 24268575)
54. J.J. Mann Neurobiology of suicidal behaviour Nat. Rev. Neurosci. 4 2003 819 828 (Pubitemid 37314404)
55. J.J. Mann, and D.M. Currier Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression Eur. Psychiatry 25 2010 268 271
56. S.J. Mathew, H.K. Manji, and D.S. Charney Novel drugs and therapeutic targets for severe mood disorders Neuropsychopharmacology 33 2008 2080 2092 (Pubitemid 351992096)
57. M.C. Mauri, A. Ferrara, L. Boscati, B. Bravin, F. Zamberlan, M. Alecci, and G. Invernizzi Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment Neuropsychobiology 37 1998 124 129 (Pubitemid 28171767)
58. J. Mogensen, G. Wörtwein, B. Gustafson, and P. Ermens l-nitroarginine reduces hippocampal mediation of place learning in the rat Neurobiol. Learn. Mem. 64 1995 17 24
59. E. Moryl, W. Danysz, and G. Quack Potential antidepressive properties of amantadine, memantine and bifemelane Pharmacol. Toxicol. 72 1993 394 397 (Pubitemid 23188507)
60. I.N. Mungrue, and D.S. Bredt nNOS at a glance: implications for brain and brawn J. Cell Sci. 117 2004 2627 2629 (Pubitemid 38997246)
61. T.J. O'Dell, R.D. Hawkins, E.R. Kandel, and O. Arancio Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger Proc. Natl. Acad. Sci. U. S. A. 88 1991 11285 11289 (Pubitemid 21916025)
62. R.M.W. Oliveira, F.S. Guimarães, and J.F. Deakin Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders Braz. J. Med. Biol. Res. 41 2008 333 341 (Pubitemid 351761067)
63. M. Papp, and E. Moryl Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression Eur. J. Pharmacol. 263 1994 1 7 (Pubitemid 24290246)
64. S. Pogun, and M.J. Kuhar Regulation of neurotransmitter reuptake by nitric oxide Ann. N. Y. Acad. Sci. 73 1994 305 315
65. S. Pogun, M.H. Baumann, and M.J. Kuhar Nitric oxide inhibits [3H] dopamine uptake Brain Res. 641 1994 83 91 (Pubitemid 24087484)
66. G. Rajkowska Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells Biol. Psychiatry 48 2000 766 777
67. G. Rajkowska, J.J. Miguel-Hidalgo, J. Wei, G. Dilley, S.D. Pittman, H.Y. Meltzer, J.C. Overholser, B.L. Roth, and C.A. Stockmeier Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression Biol. Psychiatry 45 1999 1085 1098 (Pubitemid 29236550)
68. A. Reif, C.P. Jacob, D. Rujescu, S. Herterich, S. Lang, L. Gutknecht, C.G. Baehne, A. Strobel, C.M. Freitag, I. Giegling, M. Romanos, A. Hartmann, M. Rösler, T.J. Renner, A.J. Fallgatter, W. Retz, A.C. Ehlis, and K.P. Lesch Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans Arch. Gen. Psychiatry 66 2009 41 50
69. K.J. Ressler, and C.B. Nemeroff Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol. Psychiatry 46 1999 1219 1233 (Pubitemid 30114439)
70. D. Rujescu, I. Giegling, L. Mandelli, B. Schneider, A.M. Hartmann, A. Schnabel, K. Maurer, H.J. Möller, and A. Serretti NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147 2008 42 48
71. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
72. H.A. Savas, H. Herken, M. Yürekli, E. Uz, H. Tutkun, S.S. Zoroǧlu, M.E. Ozen, B. Cengiz, and O. Akyol Possible role of nitric oxide and adrenomedullin in bipolar affective disorder Neuropsychobiology 45 2002 57 61 (Pubitemid 34224978)
73. E.M. Schuman, and D.V. Madison A requirement for the intercellular messenger nitric oxide in long-term potentiation Science 254 1991 1503 1506 (Pubitemid 21917489)
74. M.L. Selley Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression J. Affect. Disord. 80 2004 249 256 (Pubitemid 38597148)
75. S.A. Shah, P.M. Doraiswamy, M.M. Husain, P.R. Escalona, C. Na, G.S. Figiel, L.J. Patterson, E.H. Ellinwood Jr., W.M. McDonald, and O.B. Boyko Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study Acta Psychiatr. Scand. 85 1992 474 479
76. S.X. Simonian, and A.E. Herbison Localization of neuronal nitric oxide synthase immunoreactivity within sub-populations of noradrenergic A1 and A2 neurons in the rat Brain Res. 732 1996 247 252 (Pubitemid 26305313)
77. A. Spiacci Jr., F. Kanamaru, F.S. Guimarães, and R.M. Oliveira Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression Pharmacol. Biochem. Behav. 88 2008 247 255 (Pubitemid 350119843)
78. G.W. Valentine, and G. Sanacora Targeting glial physiology and glutamate cycling in the treatment of depression Biochem. Pharmacol. 78 2009 431 439
79. E.J. Van Bockstaele, and E.E. Colago Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: an immunoelectron microscopic study J. Comp. Neurol. 369 1996 483 496 (Pubitemid 26162599)
80. V. Volke, G. Wegener, M. Bourin, and E. Vasar Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2- trifluoromethylphenyl)-imidazole in mice Behav. Brain Res. 140 2003 141 147 (Pubitemid 36313249)
81. E.R. Weibel Stereological Methods: Practical Methods for Biological Morphometry 1 1979 Academic Press Inc. Orlando, Fla 186 196
82. A.K. Wiste, V. Arango, S.P. Ellis, J.J. Mann, and M.D. Underwood Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder Bipolar Disord. 10 2008 349 359 (Pubitemid 351517369)
83. G. Xing, M. Chavko, L.X. Zhang, S. Yang, and R.M. Post Decreased calcium dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression Schizophr. Res. 58 2002 21 30 (Pubitemid 35291183)
84. B. Xu, N. Wratten, E.I. Charych, S. Buyske, B.L. Firestein, and L.M. Brzustowicz Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder PLoS Med. 2 2005 e263
85. M. Yanik, H. Vural, H. Tutkun, S.S. Zoroǧlu, H.A. Savas, H. Herken, A. Koçyiǧit, H. Keles, and O. Akyol The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder Eur. Arch. Psychiatry Clin. Neurosci. 254 2004 43 47 (Pubitemid 39310548)
86. F. Yildiz, B.F. Erden, G. Ulak, T. Utkan, and N. Gacar Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats Psychopharmacology 149 2000 41 44 (Pubitemid 30187365)
87. C. Zarate Jr., R. Machado-Vieira, I. Henter, L. Ibrahim, N. Diazgranados, and G. Salvadore Glutamatergic modulators: the future of treating mood disorders? Harv. Rev. Psychiatry 18 2010 293 303
88. M.Y. Zhu, V. Klimek, G.E. Dilley, J.W. Haycock, C. Stockmeier, J.C. Overholser, H.Y. Meltzer, and G.A. Ordway Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression Biol. Psychiatry 46 1999 1275 1286 (Pubitemid 30114445)